Cafepharma Today

May 22 2025 - Sanofi inks $470M Vigil buyout, brushing off rivals' failures to join Novartis in Alzheimer's race
Sanofi inks $470M Vigil buyout, brushing off rivals' failures to join Novartis in Alzheimer's race
FDA advisors unanimously snub Pfizer's Talzenna in broader prostate cancer population
Prices for new US drugs doubled in 4 years as focus on rare disease grows
FDA expands warnings of heart risks on COVID shots
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Elan Takes Another Swing
Motley Fool
Friday, September 7, 2012 - 12:04pm
tags:
Elan, ELND005, bipolar disorder
Why Is Carl Icahn Buying Large Blocks Of Forest Laboratories?
Seeking Alpha
Friday, September 7, 2012 - 12:03pm
tags:
Forest Labs, Carl Icahn
Shire settles 1 Intuniv patent infringement lawsuit; Anchen can market generic in July 2016
Yahoo/AP
Friday, September 7, 2012 - 12:02pm
tags:
Shire, Intuniv, patents, Anchen, TWi Pharmaceuticals
Sanofi Reaches New 52-Week High
TheStreet.com
Friday, September 7, 2012 - 11:33am
tags:
Sanofi
Mylan will launch generic Detrol LA in 2014
Yahoo/AP
Friday, September 7, 2012 - 11:33am
tags:
Detrol LA, generics, Mylan, Pfizer, overactive bladder
Another Weight Loss Drug Gets Props from Wall Street
Wall St. Cheat Sheet
Friday, September 7, 2012 - 9:01am
tags:
Contrave, obesity, Orexigen
Is Tofacitinib One Of Pfizer's New Cash Cows?
Seeking Alpha
Friday, September 7, 2012 - 9:00am
tags:
Pfizer, tofacitinib, JNJ, Abbott Labs, rheumatoid arthritis
Bayer, J&J answer FDA query over wider Xarelto use
Reuters
Friday, September 7, 2012 - 8:59am
tags:
Xarelto, FDA, Bayer, JNJ, bloodthinners
Roche ramps up Alzheimer's drug trial as rivals stumble
Yahoo/Reuters
Friday, September 7, 2012 - 8:58am
tags:
Roche, Alzheimer's disease, gantenerumab
Mylan Waits Patiently at the Bottom of the Patent Cliff
Motley Fool
Thursday, September 6, 2012 - 4:23pm
tags:
patents, patent cliff, Mylan, Pfizer, Lipitor, Merck, Singulair, Plavix, Bristol-Myers Squibb
Pfizer Plays Both Sides of the Fence With Mylan
Motley Fool
Thursday, September 6, 2012 - 4:23pm
tags:
Pfizer, Mylan, generics, Japan
Roche Hosts An Encouraging Investor Day
Seeking Alpha
Thursday, September 6, 2012 - 4:15pm
tags:
Roche, JNJ, Immunogen, Abbott Labs, Illumina
FDA OKs Cancer Drugs Faster Than Other Meds
Pharmalot
Thursday, September 6, 2012 - 10:29am
tags:
cancer, FDA, approvals
Neuralstem Grants First Licenses For CNS Therapy Surgical Devices
Yahoo
Thursday, September 6, 2012 - 10:28am
tags:
Neuralstem, stem cells, CNS, ALS, Lou Gehrig's disease
Abbott to Collaborate with Astellas in CMV Vaccine Trial
Yahoo
Thursday, September 6, 2012 - 10:19am
tags:
Abbott Labs, Astellas, vaccines, CMV
Alexza Poised For Run-Up Into December U.S., EU Approval Decisions
Seeking Alpha
Thursday, September 6, 2012 - 10:17am
tags:
Alexza, FDA, Europe, Adasuve, loxapine, antipsychotic
Lilly lung cancer drug fails to meet main goal in Phase 3 study
Reuters
Thursday, September 6, 2012 - 10:07am
tags:
Alimta, lung cancer, Eli Lilly
JAMA says FDA jumped the gun on Gilenya, Pradaxa
Fierce Pharma
Thursday, September 6, 2012 - 9:33am
tags:
JAMA, FDA, Pradaxa, Gilenya, Caprelsa, Boehringer Ingelheim, Novartis, AstraZeneca
The Final Blow For Dendreon?
Seeking Alpha
Thursday, September 6, 2012 - 9:30am
tags:
Dendreon, JNJ, Xtandi, Medivation
Jazz Pharmaceuticals is selling women's health business to Meda for $95 million
Yahoo/AP
Thursday, September 6, 2012 - 9:24am
tags:
Jazz Pharmaceuticals, Women's Health, M&A, media

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.